Ubie
Active#31 in JapanEstimated valuation · AI symptom checker · Japan
AI symptom checker and medical-information platform that helps patients find conditions and clinics, plus hospital software that automates medical interviews.
Estimated valuation
AI · Japan ranking- Anchor
- Last known equity round: Series C2 · USD 43M · Oct 2022
- AI adjustment
- None
An indicative editorial estimate produced by AI, imperfect by nature: neither a financial valuation nor investment advice. Only the market sets a company’s value. Method
Uback rankings
How the AI ranks →| Ranking | Tier | Rank | Edition | Next update |
|---|---|---|---|---|
| Japan · all sectors | Top 50 | #31 | Edition 0 · October 2026 | 10 Jan 2027 |
Funding history
JPY 10.7bn+ (2022) raised in total| Date | Round | Amount | Type | Investors |
|---|---|---|---|---|
| Oct 2022 | Series C2 | USD 43M | Equity | — |
Rounds as cited by Uback’s rankings. Equity, debt and grants are shown separately; only equity rounds count towards the valuation anchor.
Independent analyses
By industry professionals & analystsIndustry professionals and financial analysts can publish their own analysis of Ubie as a PDF. It must answer at least one of these four questions, and stick to them:
Analyses are the opinion of their authors, not of Uback. They are checked before publication.
Comparable companies in Japan
Full Japan ranking →Last updated: Oct 2026Report an error
Uback is a content publisher and an aggregator of non-binding expressions of interest. It provides no investment advice, receives no mandate and takes part in no transaction. Rankings, ranges and brackets are editorial estimates produced by AI, purely indicative.